PARI products are currently being used in more than 20 clinical trials for new medications delivered by nebulizer. PARI has a proven track record for device supply and coordination of clinical trials with pharma companies. In addition, PARI products are listed in the package insert for many current medications including:

Perforomist (Dey) for COPD

Brovana® (Sepracor) for COPD

Pulmozyme® (Genentech) for cystic fibrosis<

Pulmicort Respules® (AstraZeneca) for asthma

TOBI® (Novartis) for cystic fibrosis

DuoNeb® (Dey) for COPD, asthma

AccuNeb® (Dey) for asthma

Xopenex® (Sepracor) for asthma